Successful use of inhaled epoprostenol as rescue therapy for pediatric ARDS
Severe pediatric ARDS remains a significant challenge for clinicians, and management strategies are essentially limited to lung protective ventilation strategies, and adjunct approaches such as prone positioning, steroids, surfactant, and inhaled nitric oxide in unique situations. Inhaled nitric oxi...
Main Authors: | Alissa Urich, Hammad A. Ganatra, Apurva K. Panchal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Respiratory Medicine Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007120303610 |
Similar Items
-
In-vitro and in-vivo comparisons of high versus low concentrations of inhaled epoprostenol to adult intubated patients
by: Jie Li, et al.
Published: (2021-08-01) -
Epoprostenol sodium for treatment of pulmonary arterial hypertension
by: Saito Y, et al.
Published: (2015-05-01) -
Stress Cardiomyopathy Precipitated by Withdrawal of Epoprostenol
by: William J. Gionfriddo, MD, et al.
Published: (2020-02-01) -
Effective and Safe Use of Glucocorticosteroids for Rescue of Late ARDS
by: Paolo Diana, et al.
Published: (2017-01-01) -
Case Report: Eculizumab and ECMO Rescue Therapy of Severe ARDS in Goodpasture Syndrome
by: Michael Sobotta, et al.
Published: (2021-09-01)